FLOWER MOUND, Texas, Aug. 23 /PRNewswire-FirstCall/ -- American HealthChoice, Inc. , announced today that it will be a featured presenter at the Cinapsys Microcap Investor Conference August 24th in Dallas, Texas. The conference will be held at the Intercontinental Hotel, located at 15201 Dallas Pkwy., Addison, TX, 75001. The Conference begins at 9:00 a.m. For reservations please phone 972-386-6000 and indicate the Cinapsys Conference.
The event, which spans 2 full days, is being sponsored by Securities Compliance Control, August Law Group, Hein & Associates, MarketWire, Continental Stock Transfer, Knobias, Cohen Research, StreetIQ, EPO, Vintage Filings and other notable industry providers. American HealthChoice will present in a 20 minute session followed by a question and answer period. Shareholders and interested parties are encouraged to attend the event. More details are available at: www.microcapconference.org.
This event will be webcast live and on demand also at: www.wallstreetwebcast.com.
About American HealthChoice
American HealthChoice is a medical services company comprised of a parent company and 35 owned and affiliated medical clinics in Texas and Tennessee.
About the Cinapsys Microcap Conference
The Cinapsys Microcap Conferences provide a concentrated forum where institutional and retail investors can meet and network with the executives of growth companies hand picked by Cinapsys staff. The conference will highlight approximately a dozen companies from industry groups including Energy, Technology, Business Services and more.
For information about the conference visit: http://www.microcapconference.org.
Safe Harbor Statement
The statements in this release that relate to future plans, expectations, events, performance, and the like are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the Securities Exchange Act of 1934. Actual results or events could differ materially from those described in the forward-looking statements due to a variety of factors, including those set forth in the company's report on Form 10-KSB for fiscal year 2004 filed with the Securities and Exchange Commission on January 13, 2005.
Contact: Dr. J. W. Stucki, CEO American HealthChoice, Inc. 972/538-0122 x203 Paul Knopick E & E Communications 949/707-5365 pknopick@eandecommunications.com Cinapsys, Inc. Mark Moline or Todd Gilligan 949-497-6684 www.microcapconference.orgmark@cinapsys.com
American HealthChoiceCONTACT: Dr. J. W. Stucki, CEO of American HealthChoice, Inc.,+1-972-538-0122, ext. 203; or Paul Knopick of E & E Communications,+1-949-707-5365, pknopick@eandecommunications.com, for AmericanHealthChoice, Inc.; or Mark Moline, mark@cinapsys.com, or Todd Gilligan,both of Cinapsys, Inc., +1-949-497-6684
